Suchergebnisse - "Kappelmann, Nils"

PubPharm (7)

1

Clinical phenotypes of depressed patients with evidence of inflammation and somatic symptoms

enthalten in: Comprehensive psychoneuroendocrinology | 2021

von Foley, �. | Parkinson, J. | Kappelmann, N. | +1

2

Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19

enthalten in: Psychoneuroendocrinology | 2021

von Kappelmann, N. | Dantzer, R. | Khandaker, G.

CommentIn: Psychoneuroendocrinology. 2021 Sep;131:105359. - PMID 34303538

3

Role of inflammation in depression and anxiety : Tests for disorder specificity, linearity and potential causality of association in the UK Biobank

enthalten in: EClinicalMedicine | 2021

von Ye, Z. | Kappelmann, N. | Moser, S. | +4

4

Polygenic risk for immuno-metabolic markers and specific depressive symptoms : A multi-sample network analysis study

enthalten in: Brain, behavior, and immunity | 2021

von Kappelmann, N. | Czamara, D. | Rost, N. | +9

5

Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting : study protocol of the OPTIMA-RCT

enthalten in: BMC psychiatry | 2020

von Kopf-Beck, J. | Zimmermann, P. | Egli, S. | +10

6

Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT

enthalten in: BMC psychiatry | 2020

von Kopf-Beck, J. | Zimmermann, P. | Egli, S. | +10

7

Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT

enthalten in: BMC psychiatry | 2020

von Kopf-Beck, J. | Zimmermann, P. | Egli, S. | +10

1
[1]